Find a Tender
complete
Official procurement procedure
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B
Blood coagulants
UK
Published value
Not published
Submission deadline Not published
Lots published18
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B". Published status: complete. Published value: Value not published. 18 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
46.5Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 881 active published awards; 872 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published4 Jul 2022, 14:02 BST | Last source update4 Jul 2022, 14:02 BST | Recurring procurementNot published |
ClassificationBlood coagulants | ||
Delivery area UK | ||
OCIDocds-h6vhtk-030881 | ||
What is being bought
National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B. The framework will commence on 1 July 2022 for a period of 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 moths. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points.
What changed
From the official release history
- tender value changed
4 Jul 2022, 14:02 BST - Status changed to complete
4 Jul 2022, 14:02 BST - Official notice release published
4 Jul 2022, 14:02 BST - Submission deadline changed to published date
4 Jul 2022, 14:02 BST - Buyer information updated
4 Jul 2022, 14:02 BST - Published value updated to £500,000,000
7 Jan 2022, 13:22 GMT - Status changed to active
7 Jan 2022, 13:22 GMT - Official notice release published
7 Jan 2022, 13:22 GMT - Submission deadline changed to 14 Feb 2022, 13:00 GMT
7 Jan 2022, 13:22 GMT - Buyer information updated
7 Jan 2022, 13:22 GMT
Lots and requirements (18)
Published by the contracting authority
- Lot 1 · #1Lot 1 - eftrenonacog alfa (rFIX EHL)cancelledPublished valueNot publishedeftrenonacog alfa (rFIX EHL)Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #10Lot 10 - Factor XIII - Plasma DerivedcancelledPublished valueNot publishedFactor XIII - Plasma DerivedContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #11Lot 11 - Factor XIII - RecombinantcancelledPublished valueNot publishedFactor XIII - RecombinantContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 · #12Lot 12 - Factor VIII/ von willebrands factorcancelledPublished valueNot publishedFactor VIII/ von willebrands factorContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 5 · #13Lot 13 - Von willebrands factor - Plasma DerivedcancelledPublished valueNot publishedVon willebrands factor - Plasma DerivedContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 6 · #14Lot 14 - Von willebrands factor - RecombinantcancelledPublished valueNot publishedVon willebrands factor - RecombinantContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 7 · #15Lot 15 - Fibrinogen ConcentratecancelledPublished valueNot publishedFibrinogen ConcentrateContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 8 · #16Lot 16 - Prothrombin Complex driedcancelledPublished valueNot publishedProthrombin Complex driedContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 9 · #17Lot 17 - Protein C ConcentratecancelledPublished valueNot publishedProtein C ConcentrateContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 10 · #18Lot 18 - Fresh Frozen PlasmacancelledPublished valueNot publishedFresh Frozen PlasmaContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 11 · #2Lot 2 - albutrepenonacog alfa (rFIX EHL)cancelledPublished valueNot publishedalbutrepenonacog alfa (rFIX EHL)Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 12 · #3Lot 3 - nonacog beta pegol (rFIX EHL)cancelledPublished valueNot publishednonacog beta pegol (rFIX EHL)Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 13 · #4Lot 4 - rFIX - Standard Half LifecancelledPublished valueNot publishedrFIX - Standard Half LifeContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 14 · #5Lot 5 - Recombinant Factor VIIcancelledPublished valueNot publishedRecombinant Factor VIIContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 15 · #6Lot 6 - Porcine Factor VIII - susoctocog alfacancelledPublished valueNot publishedPorcine Factor VIII - susoctocog alfaContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 16 · #7Lot 7 - Factor VIII Inhibitor Bypassing FractioncancelledPublished valueNot publishedFactor VIII Inhibitor Bypassing FractionContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 17 · #8Lot 8 - Factor IX - High Purity Factor IXcancelledPublished valueNot publishedFactor IX - High Purity Factor IXContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 18 · #9Lot 9 - Factor XcancelledPublished valueNot publishedFactor XContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
4 Jul 2022, 14:02 BST - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1 - Contract active
Signed 15 Jun 2022, 00:00 BST · £1
Commercial outcome and competition
Awards Octapharma Limited Not published · Not published · active CSL Behring UK Ltd Not published · Not published · active Novo Nordisk Not published · Not published · active Bio Products Laboratory Ltd Not published · Not published · active Bio Products Laboratory Ltd Not published · Not published · active Takeda UK Ltd Not published · Not published · active LFB Not published · Not published · active Octapharma Limited Not published · Not published · active CSL Behring UK Ltd Not published · Not published · active Takeda UK Ltd Not published · Not published · active Novo Nordisk Not published · Not published · active Octapharma Limited Not published · Not published · active LFB Not published · Not published · active Pfizer Ltd Not published · Not published · active Takeda UK Ltd Not published · Not published · active Novo Nordisk Not published · Not published · active CSL Behring UK Ltd Not published · Not published · active Sobi (Swedish Orphan Biovitrum Ltd) Not published · Not published · active CSL Behring UK Ltd Not published · Not published · active Takeda UK Ltd Not published · Not published · active Octapharma Limited Not published · Not published · active CSL Behring UK Ltd Not published · Not published · active LFB Not published · Not published · active Takeda UK Ltd Not published · Not published · active Takeda UK Ltd Not published · Not published · active |
Contracts Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B p £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B p £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B Lot 1 - eftrenonacog alfa (rFIX EHL) £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active Bleeding Disorders including Haemophilia B £1 · signed 15 Jun 2022, 00:00 BST · active |
Bid statistics bids: 1 bids: 2 bids: 2 bids: 4 bids: 1 bids: 1 bids: 1 bids: 4 bids: 3 bids: 3 bids: 3 bids: 1 bids: 1 bids: 1 bids: 1 bids: 1 bids: 4 bids: 1 bids: 1 bids: 1 bids: 2 bids: 2 bids: 1 bids: 2 bids: 2 electronicBids: 4 electronicBids: 2 electronicBids: 2 electronicBids: 2 electronicBids: 1 electronicBids: 1 electronicBids: 1 electronicBids: 4 electronicBids: 4 electronicBids: 3 electronicBids: 3 electronicBids: 3 electronicBids: 1 electronicBids: 1 electronicBids: 1 electronicBids: 1 electronicBids: 1 electronicBids: 1 electronicBids: 1 electronicBids: 1 electronicBids: 1 electronicBids: 2 electronicBids: 2 electronicBids: 1 electronicBids: 2 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromEU: 0 foreignBidsFromNonEU: 2 foreignBidsFromNonEU: 2 foreignBidsFromNonEU: 1 foreignBidsFromNonEU: 1 foreignBidsFromNonEU: 1 foreignBidsFromNonEU: 4 foreignBidsFromNonEU: 4 foreignBidsFromNonEU: 3 foreignBidsFromNonEU: 3 foreignBidsFromNonEU: 3 foreignBidsFromNonEU: 1 foreignBidsFromNonEU: 1 foreignBidsFromNonEU: 1 foreignBidsFromNonEU: 1 foreignBidsFromNonEU: 1 foreignBidsFromNonEU: 1 foreignBidsFromNonEU: 1 foreignBidsFromNonEU: 1 foreignBidsFromNonEU: 1 foreignBidsFromNonEU: 2 foreignBidsFromNonEU: 2 foreignBidsFromNonEU: 1 foreignBidsFromNonEU: 4 foreignBidsFromNonEU: 2 foreignBidsFromNonEU: 2 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 1 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 smeBids: 0 |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-FTS-3022Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published